Medication info
Aklan Tablet 625 mg

Aklan Tablet 625 mg

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
White or almost white oval film-coated tablet
Packaging
40 tablets (4 tablets/PTP*10)
Approval status
Active

MFDS item code 201307108 · Approved 2013.04.29 · Insurance code 653402740

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, skin, bone, and dental infections, and genitourinary infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)
Child dose
Children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, skin, bone, and dental infections, and genitourinary infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic inflammatory disease
View approved original text

This medication is effective for the treatment of various infections caused by a variety of bacteria. It is used for respiratory infections such as acute and chronic bronchitis, lobar pneumonia, bronchopneumonia, empyema, and lung abscesses. It is also effective for upper respiratory infections such as tonsillitis, sinusitis, and otitis media. For urogenital infections, it is used to treat cystitis, urethritis, pyelonephritis, pelvic inflammatory disease, and gonorrhea. It is also helpful for skin and soft tissue infections such as boils, abscesses, soft tissue infections, and wound infections, and is applied to the treatment of osteomyelitis and dental infections. It is widely used for the improvement of such diverse infections.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the start of a meal. Adults: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanic acid decrease.)

Child dose

Children 12 years of age or older or weighing 40 kg or more: Administer orally 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, 3 times daily every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. Children: Reduce the dose in the same manner.

Precautions

This medicine should not be used in patients with certain allergic reactions. Caution is especially necessary for those who have a history of hypersensitivity to beta-lactam antibiotics. Patients with viral infections such as infectious mononucleosis or lymphocytic leukemia are at a higher risk of developing rashes and should avoid the use of this medicine. Patients with a history of liver function problems should also be cautious as re-administration of this drug may lead to liver damage. Patients with impaired liver function or moderate to severe renal dysfunction may experience increased drug concentrations; therefore, careful administration and adjustment of dosing intervals are required. Patients with allergic constitutions or those who frequently experience symptoms such as asthma or skin rashes should be cautious when taking this medicine. Patients with gastrointestinal diseases or severe vomiting and diarrhea should be careful as the drug may not be properly absorbed. This medicine can cause various gastrointestinal side effects, so if symptoms such as diarrhea, abdominal pain, or vomiting occur, it is important to consult a doctor immediately. Liver function tests may be required during long-term use as liver enzyme levels may temporarily rise or symptoms like hepatitis and jaundice can rarely occur. Rarely, severe skin reactions or anaphylactic shocks can occur, so if symptoms such as rash or difficulty breathing appear, the medication should be stopped immediately and medical consultation should be sought. Blood components may be affected, potentially causing leukopenia or anemia in blood tests, and patients with a tendency to bleed should be particularly cautious. Rarely, unusual reactions may occur in the central nervous system, and immediate treatment is necessary if seizures or changes in consciousness arise. Kidney function may deteriorate rapidly, so regular kidney function tests are required, and if any signs of abnormality appear, the use of the drug should be stopped. This drug can disrupt the balance of intestinal bacteria, potentially leading to infections such as stomatitis or candidiasis, so any symptoms should be reported immediately. There is a risk of bleeding due to vitamin K deficiency, so long-term users or the elderly should be closely monitored for bleeding symptoms. This drug can interact with other medications, especially when taken with anticoagulants or other antibiotics, so patients should inform their doctor and pharmacist, and regular testing is necessary. It is advised to avoid taking this medication during the first trimester of pregnancy, and caution is needed while breastfeeding as side effects may occur in the baby. Children under 12 years of age or weighing less than 40 kg have limited experience with this medication and its use is not recommended. Elderly patients may experience adverse reactions more readily due to decreased bodily function, so doses and intervals should be adjusted, and their condition should be checked frequently. In case of overdose, gastrointestinal symptoms, increased activity, drowsiness, etc. may occur; in severe cases, emergency treatment should be sought immediately. This medicine should be stored in a sealed container that prevents moisture, and should be kept in a cool place between 1°C and 25°C. It is important to avoid direct sunlight or excessively hot places for storage.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stool, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, increased serum bilirubin, hepatitis, cholestatic jaundice, itching, polycyclic erythema, mucocutaneous syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized pustular psoriasis, drug reactions associated with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased secretion, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, anti-cholinergic effects, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, linear IgA disease, taste disturbances, fatigue, dermatitis, oral edema, abdominal pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, decreased urination, interstitial seizures, anaphylactic shock, skin reactions, bleeding, pancytopenia, vomiting, fungal colonization of mucosa, skin rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container that prevents moisture, and it should be maintained at a cool temperature between 1°C and 25°C during storage. It is important to avoid direct sunlight or excessively hot places.

Appearance and packaging

Appearance

White or almost white oval film-coated tablet

Package unit

40 tablets (4 tablets/PTP*10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.